Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '336, Why it was "Much ado about nothing"

'336, Why it was "Much ado about nothing"

posted on Apr 07, 2009 10:40AM

All parties having any portion of the ownership in the patent property must act together as a composite entity in patent matters before the Office

http://www.uspto.gov/web/offices/pac...



Any suggestion that PTSC should view the dispute between Moore and TPL as Material or so serious so as to negatively impact future PTO decisions, given Mr Moore's assurances, would appear to be FUD, in my very humble opinion.

If they don't work together there are no licensing revenues.

Unless, of course, it is being suggested that as a matter of principle Moore is withdrawing his presence from all PTO matters. (Think about it!) Then that would be a Material Event.





Be well

Share
New Message
Please login to post a reply